Comparison of Liver Biopsy Versus Fibroscan With CAP ( Controlled Attenuation Parameter) in Donors Evaluation for Liver Transplant

Starting soon

Conditions studied: Non-invasive Donor Liver Assessment

In brief

In our study we aiming that liver biopsy histological analysis as a reference standard, to examine the precision of fbroscan controlled attenuation parameter (CAP) for quantitative evaluation of macrovesicular steatosis in living related liver donors.

Key facts

Study ID

NCT07451379

Run by

Assiut University

People needed

100

Starts

2026-07-01

Expected to finish

2027-07-01

Last updated by the study team

2026-03-05

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All donors aged >18 years old
• eligible for Liver Transplant

You may not qualify if…

• -Subjects aged ≤18 years old.
• Donors refused to do FibroScan with CAP

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.